Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Correction: Targeting the a4-a5 dimerization interface of K-RAS inhibits tumor formation in vivo.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Correction: Targeting the a4-a5 dimerization interface of K-RAS inhibits tumor formation in vivo.
Correction: Targeting the a4-a5 dimerization interface of K-RAS inhibits tumor formation in vivo. Oncogene. 2019 May; 38(22):4426.
View in:
PubMed
authors with profiles
John P. O'Bryan